MimiX Biotherapeutics
Neuchâtel
About MimiX Biotherapeutics
mimiX Biotherapeutics aims to deliver the next generation biofabrication technology, that will enable tissue manufacturing for therapeutic and diagnostic purposes. mimiX Biotherapeutics will make this vision a reality by providing an ultra-fast biomanufacturing technology capable of creating point-of-care patient-specific biological tissue equivalents for regenerative, personalized, and precision medicine.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $10.4K
- Funding stage: Early Stage Venture
- Last round: Series A (Oct 2023)
- Website: mimixbio.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Diagnostics, Manufacturing, Precision Medicine, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/mimix-biotherapeutics-221358 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.